Slingshot AI, a mental health chatbot startup, has successfully raised $30 million in a funding round led by Andreessen Horowitz, one of the most influential venture capital firms globally. This funding round, reported by Business Insider, has placed Slingshot AI’s valuation at over $100 million. The startup also secured an additional “fast-follow round” led by Menlo Ventures, which increased its valuation to $220 million.
Based in New York City, Slingshot AI describes itself as an AI research company focused on understanding human nature in ways that have not been achieved before. Their primary product, a mental health chatbot named Ash, is designed to assist users with “subclinical issues” such as sadness, stress, life challenges, and relationship problems.
Slingshot AI was founded by Daniel Cahn and Neil Parikh. Parikh, also known for co-founding Casper Sleep, has had a notable entrepreneurial journey, with Casper Sleep experiencing a fluctuating financial history, including a significant IPO and later being taken private.
In developing Ash, Cahn and Parikh conducted extensive research, interviewing over 100 therapists and numerous crisis lines to shape their perspective on AI’s role in mental health. They discovered a significant interest within the mental health community in using AI to address the high demand for mental health services.
While mental health chatbots like Ash represent a growing trend in behavioral health, their role remains controversial. AI-powered tools are seen as potentially useful for prevention and out-of-care support, but there are concerns about their ability to handle acute behavioral health crises and protect user data. A recent survey revealed that only 29% of Americans trust AI chatbots to provide accurate health information, with slightly higher trust among AI users at 36%.
Critics argue that these tools could undermine the therapeutic alliance, a crucial factor in successful mental health treatment, and may be perceived as a substitute for professional clinicians. Despite these concerns, many in the behavioral health industry are optimistic about the potential for AI tools to reduce administrative burdens on clinicians and standardize practices.
Related topics:
